Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Stefanie Wiebe"'
Autor:
Rose K.C. Moritz, MD, Dieter Metze, MD, Stefanie Wiebe, MD, Andrea Kerkhoff, MD, Wolfgang E. Berdel, MD, Carsten Weishaupt, MD
Publikováno v:
JAAD Case Reports, Vol 4, Iss 3, Pp 270-273 (2018)
Externí odkaz:
https://doaj.org/article/f230296f04ef4f05a274c217d83c7c2c
Autor:
Christoph Schliemann, Joachim Gerss, Stefanie Wiebe, Jan-Henrik Mikesch, Nicola Knoblauch, Tim Sauer, Linus Angenendt, Tobias Kewitz, Marc Urban, Trude Butterfass-Bahloul, Sabine Edemir, Kerstin Vehring, Carsten Müller-Tidow, Wolfgang E Berdel, Utz Krug
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164499 (2016)
Nintedanib (BIBF 1120), a potent multikinase inhibitor of VEGFR-1/-2/-3, FGFR-1/-2/-3 and PDGFR-α/-β, exerts growth inhibitory and pro-apoptotic effects in myeloid leukemic cells, especially when used in combination with cytarabine. This phase I st
Externí odkaz:
https://doaj.org/article/91cee16176f940419d5015e35524e8d8
Autor:
Ann-Christin E Brehler, Wolfgang Hartmann, Stefanie Wiebe, Andrea Kerkhoff, Christoph Schliemann, Daniel Palmes, Norbert Senninger, Frank Lenze, Hansjoerg Ullerich, Wolfgang E Berdel, Torsten Kessler
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122974 (2015)
BACKGROUND:Perioperative chemotherapy increases the overall and progression-free survival of patients suffering from resectable adenocarcinomas of the lower esophagus, gastroesophageal junction and stomach (GEC). Comparing different chemotherapy regi
Externí odkaz:
https://doaj.org/article/5166088b094d4172be6acdf417ed090c
Autor:
Andrea Kerkhoff, Wolfgang E. Berdel, Rose K.C. Moritz, Carsten Weishaupt, Dieter Metze, Stefanie Wiebe
Publikováno v:
JAAD Case Reports, Vol 4, Iss 3, Pp 270-273 (2018)
JAAD Case Reports
JAAD Case Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4b4cef0fe266e3c6e985ee3ad19b3d
http://www.sciencedirect.com/science/article/pii/S2352512617302321
http://www.sciencedirect.com/science/article/pii/S2352512617302321
Autor:
Christian Wilms, Kristina Middelberg-Bisping, Karsten Kratz-Albers, Christoph Schliemann, Christian Schwöppe, Mirjam Gerwing, Hartmut Schmidt, Georg Lenz, Bjorna Berning, Wolfgang E. Berdel, Wolfgang Hartmann, Hauke Heinzow, Andrew F. Berdel, Joachim Gerss, Eike Bormann, Torsten Kessler, Saliha Harrach, Ursula Stalmann, Moritz Wildgruber, Linus Angenendt, Stefanie Wiebe, Jörn C. Albring, Walter Heindel, Rolf M. Mesters, Tobias Krähling, Eva Wardelmann, Anna Hansmeier
Publikováno v:
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1488, p 1488 (2020)
Volume 12
Issue 6
Cancers, Vol 12, Iss 1488, p 1488 (2020)
Background: Aminopeptidase N (CD13) is present on tumor vasculature cells and some tumor cells. Truncated tissue factor (tTF) with a C-terminal NGR-peptide (tTF-NGR) binds to CD13 and causes tumor vascular thrombosis with infarction. Methods: We trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904a261c2977d8190201cd4179bdc920
https://doi.org/10.3390/cancers12061488
https://doi.org/10.3390/cancers12061488
Autor:
Annika Rudat, Christian Wenning, Michael Schäfers, Fabian Wötzel, Jan-Henrik Mikesch, Stefanie Wiebe, Christoph Schliemann, Eva Wardelmann, Wolfgang E. Berdel, Linus Angenendt, Andrea Kerkhoff, Matthias Stelljes, Torsten Kessler
Publikováno v:
Annals of Hematology. 94:1241-1243
Dear Editor, Multicentric Castleman’s disease (MCD) is a rare lymphoproliferative disorder characterized by hypercytokinemia, undulating signs of systemic inflammation, generalized lymphadenopathy, hepatosplenomegaly, and in severe cases vascular l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9df60782266b2b3024f6524f0b350bb0
https://doi.org/10.1007/s00277-015-2353-8
https://doi.org/10.1007/s00277-015-2353-8
Autor:
Wolf-Karsten Hofmann, Gesine Bug, Arnold Ganser, Stefanie Wiebe, Dieter Hoelzer, Stefan Klein, Gudrun Göhring, Wolfgang Heit, Oliver G. Ottmann, Steffen Koschmieder, Felicitas Thol, Juergen Krauter, Michael Heuser, Gerd Wegener
Publikováno v:
Annals of Hematology. 93:193-202
Few studies have evaluated granulocyte colony-stimulating factor (G-CSF) priming in elderly patients with intensively treated acute myeloid leukemia (AML), and no data are available for genetically defined AML subgroups. We provide long-term results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a612436ed5e8dd20dd1688ef1ae29a07
https://doi.org/10.1007/s00277-013-1873-3
https://doi.org/10.1007/s00277-013-1873-3
Autor:
Rolf M. Mesters, Linus Angenendt, Andrea Kerkhoff, Bianca Altvater, Leonardo Giovannoni, Christoph Schliemann, Katrin L. Gutbrodt, Michael Schäfers, Inga Grünewald, Claudia Rossig, Stefanie Wiebe, Eva Wardelmann, Dario Neri, Gabriele Köhler, Wolfgang E. Berdel, Michele Pohlen, Matthias Stelljes, Gerda Silling, Torsten Kessler
Publikováno v:
Publons
ResearcherID
ResearcherID
The tumor-directed delivery of therapeutics using monoclonal antibodies specific to a tumor-associated antigen promises to accumulate large doses of the delivered payload at the tumor site while sparing healthy organs. The antibody-based delivery of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::596ba5863a8cfc02809b79a1a9d6f5d8
https://pubmed.ncbi.nlm.nih.gov/25672398
https://pubmed.ncbi.nlm.nih.gov/25672398
Acral Necrosis after Inadequate Excessive Administration of Bleomycin in a Testicular Cancer Patient
Publikováno v:
Oncology Research and Treatment. 28:41-43
Background: Testicular cancer has a favorable prognosis in the majority of patients due to the excellent susceptibility to chemotherapy with cisplatin, etoposide and bleomycin (BEP), which is commonly administered over 3-4 cycles of treatment. Case R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fbb78b18fbe4a0ce34528f1c11062a6
https://doi.org/10.1159/000082054
https://doi.org/10.1159/000082054
Autor:
C. B. Koelbel, Stefanie Wiebe, Gerhard Heil, J. T. Fischer, Wolf-K. Hofmann, W. Langer, M. Westerhausen, C. Zander, K. Hoeffken, Arnold Ganser, Alexander Knuth, Lothar Bergmann, Dieter Hoelzer, Hans-Joachim Schmoll, Oliver G. Ottmann, Karin Kolbe
Publikováno v:
Annals of hematology. 83(8)
In an attempt to improve the complete remission (CR) rates and to prolong the remission duration especially in elderly patients50 years of age, we have used a combination chemotherapy of idarubicin (10 mg/m2 IV x 3 days), cytarabine (AraC, 100 mg/m2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29bf490ab9f4ff232e5e95b4dba1785
https://pubmed.ncbi.nlm.nih.gov/15156346
https://pubmed.ncbi.nlm.nih.gov/15156346